Athos Bousvaros

15.6k total citations · 3 hit papers
159 papers, 9.8k citations indexed

About

Athos Bousvaros is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Athos Bousvaros has authored 159 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Genetics, 71 papers in Epidemiology and 44 papers in Surgery. Recurrent topics in Athos Bousvaros's work include Inflammatory Bowel Disease (82 papers), Microscopic Colitis (62 papers) and Adolescent and Pediatric Healthcare (32 papers). Athos Bousvaros is often cited by papers focused on Inflammatory Bowel Disease (82 papers), Microscopic Colitis (62 papers) and Adolescent and Pediatric Healthcare (32 papers). Athos Bousvaros collaborates with scholars based in United States, Canada and United Kingdom. Athos Bousvaros's co-authors include Neal S. LeLeiko, Shiraz A. Shah, Lorry G. Rubin, Marcie Tomblyn, Insoo Kang, Harry Keyserling, Lillian Sung, Myron J. Levin, E. Graham Davies and Shireesha Dhanireddy and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Athos Bousvaros

149 papers receiving 9.5k citations

Hit Papers

Dysfunction of the intestinal microbiome in inflammatory ... 2012 2026 2016 2021 2012 2013 2014 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
    2012 2.0k citations Neal S. LeLeiko, Scott B. Snapper et al. profile →
  2. 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
    2013 1.1k citations Athos Bousvaros et al. profile →
  3. Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
    2014 649 citations Athos Bousvaros et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Athos Bousvaros United States 46 4.1k 3.9k 2.2k 2.0k 1.4k 159 9.8k
Richard B. Gearry New Zealand 52 4.5k 1.1× 3.2k 0.8× 1.3k 0.6× 2.5k 1.3× 1.0k 0.7× 311 9.5k
Andrew S. Day New Zealand 51 3.6k 0.9× 2.6k 0.7× 1.7k 0.8× 3.0k 1.5× 748 0.5× 353 8.4k
Anthony Otley Canada 43 4.4k 1.1× 3.1k 0.8× 1.2k 0.6× 1.8k 0.9× 629 0.4× 167 6.8k
Marla C. Dubinsky United States 57 7.1k 1.7× 5.1k 1.3× 1.4k 0.6× 3.2k 1.7× 1.1k 0.8× 459 12.2k
Barbara S. Kirschner United States 42 6.5k 1.6× 3.9k 1.0× 1.7k 0.8× 3.1k 1.6× 683 0.5× 134 10.7k
Dan Turner Israel 54 9.2k 2.2× 6.9k 1.8× 2.7k 1.2× 4.2k 2.2× 2.5k 1.7× 339 15.7k
David G. Binion United States 59 4.9k 1.2× 5.7k 1.5× 1.8k 0.8× 3.5k 1.8× 2.5k 1.8× 327 12.2k
Neal S. LeLeiko United States 40 2.8k 0.7× 2.0k 0.5× 2.3k 1.0× 1.6k 0.8× 886 0.6× 163 6.7k
Robert N. Baldassano United States 58 7.0k 1.7× 4.9k 1.3× 6.7k 3.1× 3.1k 1.6× 2.2k 1.5× 251 17.1k
Paolo Lionetti Italy 34 2.4k 0.6× 1.8k 0.5× 4.2k 1.9× 1.7k 0.8× 1.2k 0.8× 139 8.8k

Countries citing papers authored by Athos Bousvaros

Since Specialization
Citations

This map shows the geographic impact of Athos Bousvaros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athos Bousvaros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athos Bousvaros more than expected).

Fields of papers citing papers by Athos Bousvaros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Athos Bousvaros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athos Bousvaros. The network helps show where Athos Bousvaros may publish in the future.

Co-authorship network of co-authors of Athos Bousvaros

This figure shows the co-authorship network connecting the top 25 collaborators of Athos Bousvaros. A scholar is included among the top collaborators of Athos Bousvaros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Athos Bousvaros. Athos Bousvaros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chan, Christina K., Athos Bousvaros, Jeffrey D. Goldsmith, Enju Liu, & Silvana Bonilla. (2025). Antimicrobial susceptibility‐guided treatment is superior to empiric therapy for Helicobacter pylori infection in children. Journal of Pediatric Gastroenterology and Nutrition. 81(5). 1133–1141.
2.
Wang, Sophia, Laurie N. Fishman, Paul A. Rufo, et al.. (2025). Clinical outcomes of maintenance therapy with sulfasalazine compared to 5‐aminosalicylates in children with ulcerative colitis. Journal of Pediatric Gastroenterology and Nutrition. 80(6). 988–997. 2 indexed citations
3.
Weaver, Kimberly N., Xian Zhang, Xiangfeng Dai, et al.. (2021). Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID. Inflammatory Bowel Diseases. 28(10). 1497–1505. 63 indexed citations
4.
Kurugol, Sila, Moti Freiman, Jeannette M. Pérez-Rosselló, et al.. (2018). Curved planar reformatting and convolutional neural network‐based segmentation of the small bowel for visualization and quantitative assessment of pediatric Crohn's disease from MRI. Journal of Magnetic Resonance Imaging. 49(6). 1565–1576. 28 indexed citations
5.
Goettel, Jeremy A., Daniel Kotlarz, David W. Illig, et al.. (2017). O-011 Low-dose IL-2 Administration Expands Human Regulatory T Cells in Patients with UC and Humanized Mice and Protects Against Experimental Colitis.. Inflammatory Bowel Diseases. 23. 3 indexed citations
6.
Badran, Yousef R., Fatma Dedeoğlu, Juan Manuel Leyva-Castillo, et al.. (2017). Human RELA haploinsufficiency results in autosomal-dominant chronic mucocutaneous ulceration. The Journal of Experimental Medicine. 214(7). 1937–1947. 69 indexed citations
7.
Pacak, Christina A., et al.. (2016). Longitudinal Patterns of Thalidomide Neuropathy in Children and Adolescents. The Journal of Pediatrics. 178. 227–232. 8 indexed citations
8.
Turner, Dan, Etti Doveh, Ayala Cohen, et al.. (2014). Efficacy of oral methotrexate in paediatric Crohn’s disease: a multicentre propensity score study. Gut. 64(12). 1898–1904. 26 indexed citations
9.
Lamousé‐Smith, Esi, Sarah Weber, Nima Mosammaparast, et al.. (2013). Polymerase Chain Reaction Test for Clostridium difficile Toxin B Gene Reveals Similar Prevalence Rates in Children With and Without Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 57(3). 293–297. 16 indexed citations
10.
Srinath, Arvind I., Margaret A. Kirshner, David J. Keljo, et al.. (2011). The effect of therapy on cost utilization in children with inflammatory bowel disease.. Inflammatory Bowel Diseases. 17(suppl_1). S10–S10. 1 indexed citations
11.
Watson, Sheree L., Licia Pensabene, Paul D. Mitchell, & Athos Bousvaros. (2010). Outcomes and adverse events in children and young adults undergoing tacrolimus therapy for steroid-refractory colitis. Inflammatory Bowel Diseases. 17(1). 22–29. 38 indexed citations
12.
Punati, Jaya, James Markowitz, Trudy Lerer, et al.. (2008). Effect of early immunomodulator use in moderate to severe pediatric Crohn disease. Inflammatory Bowel Diseases. 14(7). 949–954. 83 indexed citations
13.
Szigethy, Eva, Johanna Carpenter, Diana Hardy, et al.. (2007). Cognitive-Behavioral Therapy for Adolescents With Inflammatory Bowel Disease and Subsyndromal Depression. Journal of the American Academy of Child & Adolescent Psychiatry. 46(10). 1290–1298. 139 indexed citations
14.
Griffiths, Anne M., Anthony Otley, Jeffrey S. Hyams, et al.. (2005). A Review of Activity Indices and End Points for Clinical Trials in Children with Crohnʼs Disease. Inflammatory Bowel Diseases. 11(2). 185–196. 53 indexed citations
15.
Szigethy, Eva, Sarah W. Whitton, Athos Bousvaros, et al.. (2004). Depressive Symptoms and Inflammatory Bowel Disease in Children and Adolescents: A Cross‐Sectional Study. Journal of Pediatric Gastroenterology and Nutrition. 39(4). 395–403. 5 indexed citations
16.
Hyams, Jeffrey S., James Markowitz, Anne M. Griffiths, et al.. (2004). P0666 LAB PARAMETERS IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE (IBD) AT DIAGNOSIS. Journal of Pediatric Gastroenterology and Nutrition. 39(Supplement 1). S310–S310. 1 indexed citations
17.
Heuschkel, Robert, Nadeem Afzal, David Zurakowski, et al.. (2002). Complementary medicine use in children and young adults with inflammatory bowel disease. The American Journal of Gastroenterology. 97(2). 382–388. 99 indexed citations
18.
Verhave, Menno, Robert N. Baldassano, Athos Bousvaros, Richard J. Grand, & Barbara S. Kirschner. (2002). Research Agenda for Pediatric Gastroenterology, Hepatology and Nutrition: Chronic Inflammatory Bowel Disease: Report of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition for the Children's Digestive Health and Nutrition Foundation. Journal of Pediatric Gastroenterology and Nutrition. 35. S286–S290. 1 indexed citations
19.
Rosen, Rachel, Mark J. Integlia, & Athos Bousvaros. (2002). Severe Pancytopenia from Thiopurine Methyltransferase Deficiency: A Preventable Complication of 6‐Mercaptopurine Therapy in Children With Crohn Disease. Journal of Pediatric Gastroenterology and Nutrition. 35(5). 695–699. 1 indexed citations
20.
Srivastava, Maya D., et al.. (2001). Elevated Serum Hepatocyte Growth Factor in Children and Young Adults With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 33(5). 548–553.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard B. Gearry Breakdown of academic impact, for papers by Andrew S. Day Breakdown of academic impact, for papers by Anthony Otley Breakdown of academic impact, for papers by Marla C. Dubinsky Breakdown of academic impact, for papers by Barbara S. Kirschner Breakdown of academic impact, for papers by Dan Turner Breakdown of academic impact, for papers by David G. Binion Breakdown of academic impact, for papers by Neal S. LeLeiko Breakdown of academic impact, for papers by Robert N. Baldassano Breakdown of academic impact, for papers by Paolo Lionetti
Rankless by CCL
2026